(Q34418770)

2 August 2017

title

In vitro effects of inogatran, a selective low molecular weight thrombin inhibitor (English)

1 reference

2 August 2017

Teger-Nilsson AC

1

1 reference

2 August 2017

Bylund R

2

1 reference

2 August 2017

Gustafsson D

3

1 reference

2 August 2017

Gyzander E

4

1 reference

2 August 2017

Eriksson U

5

1 reference

2 August 2017

publication date

1 January 1997

1 reference

2 August 2017

1 reference

2 August 2017

volume

85

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

133-145

1 reference

The development of hirudin as an antithrombotic drug

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900230-7

7 January 2021

Design and synthesis of potent and highly selective thrombin inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900230-7

7 January 2021

D-PHE-PRO-ARGCH2Cl-A selective affinity label for thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900230-7

7 January 2021

Highly active and selective anticoagulants: D-Phe-Pro-Arg-H, a free tripeptide aldehyde prone to spontaneous inactivation, and its stable N-methyl derivative, D-MePhe-Pro-Arg-H

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900230-7

7 January 2021

Thrombin inhibitors based on ketone derivatives of arginine and lysine

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900230-7

7 January 2021

Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900230-7

7 January 2021

Kinetics of the inhibition of thrombin by hirudin.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900230-7

7 January 2021

Effects of inogatran, a new low-molecular-weight thrombin inhibitor, in rat models of venous and arterial thrombosis, thrombolysis and bleeding time.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900230-7

7 January 2021

Aspirin does not potentiate effect of suboptimal dose of the thrombin inhibitor inogatran during coronary thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900230-7

7 January 2021

Antithrombotic activity of inogatran, a new low-molecular-weight inhibitor of thrombin, in a closed-chest porcine model of coronary artery thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900230-7

7 January 2021

10.1016/S0049-3848(96)00230-7

Identifiers

DOI

1 reference

2 August 2017

1 reference